Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.13
-0.05 (-0.81%)
At close: Apr 22, 2026, 4:00 PM EDT
6.06
-0.07 (-1.14%)
After-hours: Apr 22, 2026, 7:58 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $19.66 million as of April 22, 2026. Its market cap has decreased by -6.94% in one year.
Market Cap
19.66M
Enterprise Value
-2.69M
1-Year Change
-6.94%
Ranking
Category
Stock Price
$6.13
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $19.66M, a decrease of -97.94%. That is a compound annual growth rate of -46.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 19.82M | -47.15% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 22.50M |
| Allarity Therapeutics | 22.25M |
| Quince Therapeutics | 21.92M |
| VYNE Therapeutics | 21.31M |
| Traws Pharma | 21.14M |
| OSR Holdings | 20.15M |
| Cocrystal Pharma | 19.99M |
| Citius Pharmaceuticals | 18.85M |